Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 21 May 2026 for Biomarin Pharmaceutical INC, €100k.
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Cristin Hubbard: trading record in brief
All filings by Cristin Hubbard on record concern Biomarin Pharmaceutical Inc. The record holds 9 filings, for trades running from 20 May 2024 to 20 May 2026.
Every open-market trade on record is a sale: 1 sale worth €16k. Outside the open market, there are 8 share grants.
The latest filing, published on 21 May 2026, reports a share grant of €100k in Biomarin Pharmaceutical Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Cristin Hubbard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
2,318 shares@ US$50.200.0009% mcap44.0% of flowCommon StockSEC:0001628280-26-037455:0
15,410 shares0Common StockSEC:0001628280-26-019269:0
2,155 shares@ US$59.9350.3% of flowCommon StockSEC:0001048477-25-000080:0
273 shares@ US$54.1375.7% of flowCommon StockSEC:0001048477-25-000053:0
13,310 shares0Common StockSEC:0001048477-25-000035:0
14,690 shares0Common StockSEC:0001048477-24-000090:0
6 of 6 declarations
